Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |